GlaxoSmithKline: Dermatitis, Atopic trials
The registry lists 19 Dermatitis, Atopic studies with GlaxoSmithKline as lead sponsor. 0 are open to participants now and 7 have results posted.
Phase 1 9Phase 2 8Phase 3 1No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Long-Term Study (AtDvance) to Evaluate GSK1070806 in Atopic Dermatitis.TerminatedNCT06447506Phase 2Results posted
- A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic DermatitisTerminatedNCT05999799Phase 2Results posted
- An Efficacy and Safety Study of RPT193 in Adults With Atopic DermatitisTerminatedNCT05399368Phase 2Results posted
- Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic DermatitisCompletedNCT04975438Phase 1Results posted
- Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic DermatitisTerminatedNCT03055195Phase 2Results posted
- A Dose-Finding Study of GSK2894512 Cream in Subjects With Atopic Dermatitis (AD)CompletedNCT02564055Phase 2Results posted
- A Study to Test the Effect of 2 Different Doses of Topical GW870086X on Atopic Dermatitis Also Including a Postive Control and a PlaceboCompletedNCT01299610Phase 2Results posted
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic of GSK1070806 After a Single Intravenous Dose in Healthy Male and Female Caucasian, Chinese and Japanese Participants Aged 18 to 65 Years of Age InclusiveCompletedNCT05590338Phase 1
- A Multiple-Dose Study of BLU-5937 in Chronic Pruritus Associated With Atopic DermatitisCompletedNCT04693195Phase 2
- A First-in-Human Study of RPT193 in Healthy Volunteers and Patients With Atopic DermatitisCompletedNCT04271514Phase 1
- Skin Irritation Study of GSK2894512 CreamCompletedNCT02637206Phase 1
- Pharmacokinetic Study of Topical GSK2894512 CreamCompletedNCT02466152Phase 1
- A Single Dose Phase I Exploratory Study in Healthy Volunteers With GSK2894512 CreamCompletedNCT02411162Phase 1
- Place of Flixovate® in the Treatment Pathway and Its Conditions of Use in Infants Aged From 3 to 12 Months Between 2010 and 2012 by French GPs and Private PaediatriciansCompletedNCT01920464
- Investigation of Topical SB705498 on Healthy VolunteersCompletedNCT01673529Phase 1
- A Study Assessing GW870086's Potential to Cause Skin ThinningCompletedNCT01381445Phase 1
- Study Of Single And Ten Day Repeat Atopical Applications Of GW842470X Cream On The Skin Of Patients With Atopic DermatitisCompletedNCT00356642Phase 1
- Topical GW842470X In Adults Patients With Moderate Atopic DermatitisCompletedNCT00354510Phase 2
- Study Of Atopic Dermatitis In PediatricsCompletedNCT00257569Phase 3